[Erythroleukemia with double erythrocyte population: association in the same population of a weakening in a blood group antigen, a severe adenylate-kinase deficiency and an increase in the A 2  hemoglobin fraction].
D000249:Adenosine Monophosphate; D000328:Adult; D001789:Blood Group Antigens; D004592:Electrophoresis, Starch Gel; D004912:Erythrocytes / Q000201:enzymology / Q000276:immunology; D006453:Hemoglobinopathies / Q000150:complications; D006454:Hemoglobins / Q000032:analysis*; D006455:Hemoglobins, Abnormal / Q000096:biosynthesis; D006801:Humans; D007154:Immune System Diseases / Q000150:complications; D007535:Isomerases / Q000097:blood; D004915:Leukemia, Erythroblastic, Acute / Q000097:blood* / Q000150:complications / Q000201:enzymology / Q000276:immunology; D008297:Male; D008659:Metabolic Diseases / Q000150:complications; D010770:Phosphotransferases / Q000097:blood*
D001789:Blood Group Antigens; D006454:Hemoglobins; D006455:Hemoglobins, Abnormal; D000249:Adenosine Monophosphate; D010770:Phosphotransferases; D007535:Isomerases
Erythroleucémie avec double population érythrocytaire: coexistence dans une même population d'un affaiblissement d'un antigène de groupe, d'un déficit majeur en adenylate-kinase et d'une augmentation de la fraction A 2  de l'hémoglobine.